CD40L-deficient mice show deficits in antiviral immunity and have an impaired memory CD8+ CTL response
暂无分享,去创建一个
P. Borrow | R. Flavell | M. Oldstone | A. Tishon | I. Grewal | Jianchao Xu | J. Xu | S. Lee | Sherina Lee | Richard A Flaveur
[1] M. V. von Herrath,et al. CD4-deficient mice have reduced levels of memory cytotoxic T lymphocytes after immunization and show diminished resistance to subsequent virus challenge , 1996, Journal of virology.
[2] J. Banchereau,et al. CD40-CD40 ligand: a multifunctional receptor-ligand pair. , 1996, Advances in immunology.
[3] R. Flavell,et al. Impairment of antigen-specific T-cell priming in mice lacking CD40 ligand , 1995, Nature.
[4] J. Karras,et al. Induction of bcl-x by CD40 engagement rescues sIg-induced apoptosis in murine B cells. , 1995, Journal of immunology.
[5] R. Zinkernagel,et al. Antiviral protection by vesicular stomatitis virus-specific antibodies in alpha/beta interferon receptor-deficient mice , 1995, Journal of virology.
[6] R. Ahmed,et al. Bone marrow is a major site of long-term antibody production after acute viral infection , 1995, Journal of virology.
[7] P. Borrow,et al. Virus-induced immunosuppression: immune system-mediated destruction of virus-infected dendritic cells results in generalized immune suppression , 1995, Journal of virology.
[8] C. Snapper,et al. T cell-independent antigens type 2. , 1995, Annual review of immunology.
[9] A. Fischer,et al. T cell clones from an X-linked hyper-immunoglobulin (IgM) patient induce IgE synthesis in vitro despite expression of nonfunctional CD40 ligand , 1994, The Journal of experimental medicine.
[10] R J Armitage,et al. Humoral immune responses in CD40 ligand-deficient mice , 1994, The Journal of experimental medicine.
[11] R. Noelle,et al. In vivo T-B cell interactions and cytokine-production in the spleen. , 1994, Seminars in immunology.
[12] T. Foy,et al. The expansive role of CD40 and its ligand, gp39, in immunity. , 1994, Seminars in immunology.
[13] R. Flavell,et al. Mice deficient for the CD40 ligand. , 1994, Immunity.
[14] A. Saxon,et al. CD58 (LFA-3) stimulation provides a signal for human isotype switching and IgE production distinct from CD40. , 1994, Journal of immunology.
[15] R. Zinkernagel,et al. Enhanced establishment of a virus carrier state in adult CD4+ T-cell-deficient mice , 1994, Journal of virology.
[16] D. Gray,et al. Memory B cell development but not germinal center formation is impaired by in vivo blockade of CD40-CD40 ligand interaction , 1994, The Journal of experimental medicine.
[17] A. Aruffo,et al. gp39-CD40 interactions are essential for germinal center formation and the development of B cell memory , 1994, The Journal of experimental medicine.
[18] M Aguet,et al. Functional role of type I and type II interferons in antiviral defense. , 1994, Science.
[19] Peter C. Doherty,et al. Virus-specific CD8+ T-cell memory determined by clonal burst size , 1994, Nature.
[20] R. Ahmed,et al. Cytotoxic T-cell memory without antigen , 1994, Nature.
[21] R. Zinkernagel,et al. Vesicular stomatitis virus Indiana glycoprotein as a T-cell-dependent and -independent antigen , 1994, Journal of virology.
[22] R. Zinkernagel,et al. The influence of antigen organization on B cell responsiveness. , 1993, Science.
[23] A. Aruffo,et al. In vivo CD40-gp39 interactions are essential for thymus-dependent humoral immunity. I. In vivo expression of CD40 ligand, cytokines, and antibody production delineates sites of cognate T-B cell interactions , 1993, The Journal of experimental medicine.
[24] A. Aruffo,et al. In vivo CD40-gp39 interactions are essential for thymus-dependent humoral immunity. II. Prolonged suppression of the humoral immune response by an antibody to the ligand for CD40, gp39 , 1993, The Journal of experimental medicine.
[25] A. Aruffo,et al. The regulation of the expression of gp39, the CD40 ligand, on normal and cloned CD4+ T cells. , 1993, Journal of immunology.
[26] G. Mudde,et al. Induction of IgE and IgG1 in human B cell cultures with staphylococcal superantigens: role of helper T cell interaction, resistance to interferon-gamma. , 1993, Immunobiology.
[27] E. Maggi,et al. Membrane tumour necrosis factor-α is involved in the polyclonal B-cell activation induced by HIV-infected human T cells , 1993, Nature.
[28] J. Whitton,et al. A "string-of-beads" vaccine, comprising linked minigenes, confers protection from lethal-dose virus challenge , 1993, Journal of virology.
[29] J. Whitton,et al. Molecular Anatomy of the Cytotoxic T-Lymphocyte Responses to Lymphocytic Choriomeningitis Virus , 1993 .
[30] G. Inghirami,et al. Molecular interactions mediating T-B lymphocyte collaboration in human lymphoid follicles. Roles of T cell-B-cell-activating molecule (5c8 antigen) and CD40 in contact-dependent help. , 1992, Journal of immunology.
[31] I. Stamenkovic,et al. The human T cell antigen gp39, a member of the TNF gene family, is a ligand for the CD40 receptor: expression of a soluble form of gp39 with B cell co‐stimulatory activity. , 1992, The EMBO journal.
[32] C. Maliszewski,et al. Recombinant human CD40 ligand stimulates B cell proliferation and immunoglobulin E secretion , 1992, The Journal of experimental medicine.
[33] D. Gray,et al. Activated human T cells express a ligand for the human B cell‐associated antigen CD40 which participates in T cell‐dependent activation of B lymphocytes , 1992, European journal of immunology.
[34] I. Stamenkovic,et al. A 39-kDa protein on activated helper T cells binds CD40 and transduces the signal for cognate activation of B cells. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[35] G. F. Burton,et al. Germinal Centers and Antibody Production in Bone Marrow , 1992, Immunological reviews.
[36] L. Notarangelo,et al. Immunodeficiency with hyper-IgM (HIM). , 1992, Immunodeficiency reviews.
[37] R. Zinkernagel,et al. Immune response against lymphocytic choriomeningitis virus infection in mice without CD8 expression , 1991, The Journal of experimental medicine.
[38] C. Biron,et al. The role of CD4+ cells in sustaining lymphocyte proliferation during lymphocytic choriomeningitis virus infection. , 1991, Journal of immunology.
[39] I. Maclennan,et al. Mechanism of antigen-driven selection in germinal centres , 1989, Nature.
[40] J. Whitton,et al. Class I MHC can present an endogenous peptide to cytotoxic T lymphocytes , 1989, The Journal of experimental medicine.
[41] J. Whitton,et al. Analyses of the cytotoxic T lymphocyte responses to glycoprotein and nucleoprotein components of lymphocytic choriomeningitis virus. , 1988, Virology.
[42] R. Ahmed,et al. Immune therapy of a persistent and disseminated viral infection , 1987, Journal of virology.
[43] D. Moskophidis,et al. Mechanism of recovery from acute virus infection: treatment of lymphocytic choriomeningitis virus-infected mice with monoclonal antibodies reveals that Lyt-2+ T lymphocytes mediate clearance of virus and regulate the antiviral antibody response , 1987, Journal of virology.
[44] R. Zinkernagel,et al. Functional analysis of T lymphocyte subsets in antiviral host defense. , 1987, Journal of immunology.
[45] J. Holland,et al. Continuing coevolution of virus and defective interfering particles and of viral genome sequences during undiluted passages: virus mutants exhibiting nearly complete resistance to formerly dominant defective interfering particles , 1987, Journal of virology.
[46] D. Gray,et al. Antigen‐Driven Selection of Virgin and Memory B Cells , 1986, Immunological reviews.
[47] R. Zinkernagel,et al. Antibody mediated suppression of secondary IgM response in nude mice against vesicular stomatitis virus. , 1986, Journal of immunology.
[48] R. Schreiber,et al. Monoclonal antibodies to murine gamma-interferon which differentially modulate macrophage activation and antiviral activity. , 1985, Journal of immunology.
[49] H. Waldmann,et al. Therapy with monoclonal antibodies by elimination of T-cell subsets in vivo , 1984, Nature.
[50] R. Ahmed,et al. Selection of genetic variants of lymphocytic choriomeningitis virus in spleens of persistently infected mice. Role in suppression of cytotoxic T lymphocyte response and viral persistence , 1984, The Journal of experimental medicine.
[51] L. Lefrançois. Protection against lethal viral infection by neutralizing and nonneutralizing monoclonal antibodies: distinct mechanisms of action in vivo , 1984, Journal of virology.
[52] M. Oldstone,et al. Genomic and biological variation among commonly used lymphocytic choriomeningitis virus strains. , 1983, The Journal of general virology.
[53] L. Lefrançois,et al. The interaction of antibody with the major surface glycoprotein of vesicular stomatitis virus. I. Analysis of neutralizing epitopes with monoclonal antibodies. , 1982, Virology.
[54] R. Mannino,et al. The glycoprotein isolated from vesicular stomatitis virus is mitogenic for mouse B lymphocytes , 1981, The Journal of experimental medicine.
[55] M. Buchmeier,et al. Protein structure of lymphocytic choriomeningitis virus: evidence for a cell-associated precursor of the virion glycopeptides. , 1979, Virology.
[56] M. Buchmeier,et al. Variation Between Strains of Hamsters in the Lethality of Pichinde Virus Infections , 1977, Infection and immunity.
[57] I. Gresser,et al. Role of interferon in the pathogenesis of virus diseases in mice as demonstrated by the use of anti-interferon serum. II. Studies with herpes simplex, Moloney sarcoma, vesicular stomatitis, Newcastle disease, and influenza viruses , 1976, The Journal of experimental medicine.
[58] D. H. Harter,et al. NEUROPATHOLOGICAL AND IMMUNOFLUORESCENCE STUDIES OF EXPERIMENTAL VESICULAR STOMATITIS VIRUS ENCEPHALITIS IN MICE , 1971, Journal of neuropathology and experimental neurology.